Deep Track Capital, LP 13D and 13G filings for Ocular Therapeutix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-10 4:38 pm Purchase | 2026-02-05 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 11,234,132 5.130% | 2,000,000 (+21.66%) | Filing |
| 2026-02-10 09:08 am Sale | 2025-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 9,234,132 4.310% | -3,861,723 (-29.49%) | Filing |
| 2025-11-14 08:20 am Sale | 2025-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 13,095,855 6.180% | -2,362,283 (-15.28%) | Filing |
| 2025-05-15 08:45 am Purchase | 2025-03-31 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 15,458,138 9.650% | 6,227,369 (+67.46%) | Filing |
| 2023-12-22 4:04 pm Purchase | 2023-12-14 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 9,230,769 8.380% | 9,230,769 (New Position) | Filing |